SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008907
Filing Date
2018-11-08
Accepted
2018-11-08 08:46:15
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20180930x10q.htm 10-Q 2316438
2 EX-10.1 edit-20180930ex10187a2ed.htm EX-10.1 764991
3 EX-31.1 edit-20180930ex3117da9ee.htm EX-31.1 19697
4 EX-31.2 edit-20180930ex312e50489.htm EX-31.2 19257
5 EX-32.1 edit-20180930ex3213bb672.htm EX-32.1 13551
6 GRAPHIC edit20180930ex10187a2ed001.jpg GRAPHIC 49907
7 GRAPHIC edit20180930ex10187a2ed002.jpg GRAPHIC 24072
  Complete submission text file 0001558370-18-008907.txt   9053992

Data Files

Seq Description Document Type Size
8 EX-101.INS edit-20180930.xml EX-101.INS 1846573
9 EX-101.SCH edit-20180930.xsd EX-101.SCH 59534
10 EX-101.CAL edit-20180930_cal.xml EX-101.CAL 43607
11 EX-101.DEF edit-20180930_def.xml EX-101.DEF 191586
12 EX-101.LAB edit-20180930_lab.xml EX-101.LAB 475681
13 EX-101.PRE edit-20180930_pre.xml EX-101.PRE 338353
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 181168332
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences